MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1093/infdis/jiad045

Медицинская библиотека · The Journal of infectious diseases · 2023

Vaccination Ameliorates Cellular Inflammatory Responses in SARS-CoV-2 Breakthrough Infections.

Huapaya Julio A, Higgins Jeanette, Kanth Shreya, Demirkale Cumhur Y, Gairhe Salina, Aboye Etsubdink A, Regenold David, Sahagun Seynt Jiro, Pastor Gloria, Swaim Doris, Dewar Robin, Rehman Tauseef, Highbarger Helene C, Lallemand Perrine, Laverdure Sylvain, Adelsberger Joseph, Rupert Adam, Li Willy, Krack Janell, Teferi Gebeyehu, Kuruppu Janaki, Strich Jeffrey R, Davey Richard, Childs Richard, Chertow Daniel, Kovacs Joseph A, Barnett Christopher, Torabi-Parizi Parizad, Suffredini Anthony F, COVID-ARC Study Group

СтатьяResearch Support, N.I.H., IntramuralПеревод пока не подготовлен

Аннотация

BACKGROUND

Data on cellular immune responses in persons with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection following vaccination are limited. The evaluation of these patients with SARS-CoV-2 breakthrough infections may provide insight into how vaccinations limit the escalation of deleterious host inflammatory responses.

METHODS

We conducted a prospective study of peripheral blood cellular immune responses to SARS-CoV-2 infection in 21 vaccinated patients, all with mild disease, and 97 unvaccinated patients stratified based on disease severity.

RESULTS

We enrolled 118 persons (aged 50 years [SD 14.5 years], 52 women) with SARS-CoV-2 infection. Compared to unvaccinated patients, vaccinated patients with breakthrough infections had a higher percentage of antigen-presenting monocytes (HLA-DR+), mature monocytes (CD83+), functionally competent T cells (CD127+), and mature neutrophils (CD10+); and lower percentages of activated T cells (CD38+), activated neutrophils (CD64+), and immature B cells (CD127+CD19+). These differences widened with increased disease severity in unvaccinated patients. Longitudinal analysis showed that cellular activation decreased over time but persisted in unvaccinated patients with mild disease at 8-month follow-up.

CONCLUSIONS

Patients with SARS-CoV-2 breakthrough infections exhibit cellular immune responses that limit the progression of inflammatory responses and suggest mechanisms by which vaccination limits disease severity. These data may have implications for developing more effective vaccines and therapies. Clinical Trials Registration. NCT04401449.

Для цитирования: Huapaya Julio A, Higgins Jeanette, Kanth Shreya, Demirkale Cumhur Y, Gairhe Salina, Aboye Etsubdink A, Regenold David, Sahagun Seynt Jiro, Pastor Gloria, Swaim Doris, Dewar Robin, Rehman Tauseef, Highbarger Helene C, Lallemand Perrine, Laverdure Sylvain, Adelsberger Joseph, Rupert Adam, Li Willy, Krack Janell, Teferi Gebeyehu, Kuruppu Janaki, Strich Jeffrey R, Davey Richard, Childs Richard, Chertow Daniel, Kovacs Joseph A, Barnett Christopher, Torabi-Parizi Parizad, Suffredini Anthony F, COVID-ARC Study Group. Vaccination Ameliorates Cellular Inflammatory Responses in SARS-CoV-2 Breakthrough Infections.. The Journal of infectious diseases. 2023. DOI: 10.1093/infdis/jiad045.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.